Simplify Logo

Full-Time

Head of Platform

Posted on 5/28/2024

Gordian Biotechnology

Gordian Biotechnology

501-1,000 employees

Biotech startup focused on age-related disease therapies

Biotechnology
Healthcare

Senior

San Bruno, CA, USA

The job is located in South San Francisco, the biotech capital, offering onsite amenities like an onsite gym, lunch paid for 3 days a week, and access to world-class mentors and advisors. Remote work flexibility is also provided.

Category
Computational Biology
Genomics
Biology & Biotech
Requirements
  • Experience in strategic technology leadership in biotech, preferably in drug discovery
  • Familiarity with genomic datasets and challenges
  • Experience managing a collaborative team in a fast-paced environment
  • Knowledge of pooled screening, barcoding, and in vivo gene delivery and experimentation
  • Strong communication skills
Responsibilities
  • Own the application and evolution of Gordian’s mosaic screening platform
  • Lead the team producing transcriptomic data on potential therapeutic targets
  • Ensure operational excellence and efficiency of the team
  • Provide structure for achieving milestones and continuous improvement of processes
  • Guide evolution of the platform to improve predictive validity in drug development
Gordian Biotechnology

Gordian Biotechnology

View

Gordian Biotechnology focuses on developing treatments for age-related diseases through drug discovery. The company uses advanced technologies to create models that accurately reflect the biological processes of aging, which helps in testing therapies in conditions similar to those in humans. This method increases the chances of success in clinical trials. Gordian Bio primarily collaborates with pharmaceutical companies, research institutions, and healthcare providers, generating revenue through partnerships and licensing agreements. Their goal is to extend healthy human lifespan by addressing the underlying causes of age-related diseases. They utilize animal models, like fruit flies, to study aging and test new therapies, allowing for scalable and precise research. The team consists of experts in gene therapy and genome engineering, and their work has been recognized at major industry conferences.

Company Stage

M&A

Total Funding

$68.9M

Headquarters

South San Francisco, California

Founded

1990

Growth & Insights
Headcount

6 month growth

5%

1 year growth

32%

2 year growth

60%
Simplify Jobs

Simplify's Take

What believers are saying

  • Gordian Bio's $60M venture capital launch provides strong financial backing, enabling rapid advancement in their research and development efforts.
  • The company's innovative platform has already demonstrated 80% predictive accuracy in proof-of-concept experiments, indicating a high potential for clinical success.
  • Their unique approach to using animal models that closely mimic human conditions could significantly streamline the drug discovery process, reducing time and costs.

What critics are saying

  • The niche focus on age-related diseases may limit market opportunities compared to broader biotech companies.
  • Reliance on animal models, despite their advanced nature, may still face ethical and regulatory challenges that could impact research progress.

What makes Gordian Biotechnology unique

  • Gordian Bio's high-throughput in vivo screening platform allows for the simultaneous testing of hundreds of gene therapies, a capability that is unique in the biotech industry.
  • Their use of 'patient avatars' like horses and monkeys, which closely mimic human biology, enhances the predictive accuracy of their drug discovery process.
  • Gordian Bio's focus on age-related diseases and leveraging advanced technologies like single-cell sequencing sets them apart from traditional drug discovery approaches.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE